03:52 PM EDT, 07/22/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) said Tuesday afternoon it regained compliance with Nasdaq's minimum bid price requirement.

The company said it received a formal letter from the listing qualifications department of the exchange, confirming that Oncolytics met the rule by maintaining a closing bid price of at least US$1 for 10 consecutive trading days, from July 8 to July 21.

The company added that its shares will continue to trade on the Nasdaq Capital Market under the "ONCY" symbol.

The company's shares were last seen up $0.02 to $1.67 on the Toronto Stock Exchange.

Price: 1.67, Change: +0.02, Percent Change: +1.21